<DOC>
	<DOCNO>NCT00001055</DOCNO>
	<brief_summary>To evaluate safety immunogenicity ALVAC-HIV MN120TMG ( vCP205 ) comparison ALVAC-RG rabies glycoprotein ( vCP65 ) control administer HIV-1 negative volunteer . ALVAC-HIV vCP205 second generation candidate vaccine use induce humoral cellular response several antigen . This recombinant construct base canarypox vector term ALVAC express gp120 HIV MN strain , plus transmembrane portion LAI strain well gag protease .</brief_summary>
	<brief_title>A Phase I Safety Immunogenicity Trial Live Recombinant Canarypox ALVAC-HIV ( vCP205 ) HIV-1 Uninfected Adult Volunteers</brief_title>
	<detailed_description>ALVAC-HIV vCP205 second generation candidate vaccine use induce humoral cellular response several antigen . This recombinant construct base canarypox vector term ALVAC express gp120 HIV MN strain , plus transmembrane portion LAI strain well gag protease . Volunteers randomize receive dos ALVAC-HIV vCP205 ALVAC-HIV vCP65 control accord vary schedule 12 month ( 6 month , amend 11/17/95 ) 12 month follow . [ AS PER AMENDMENT 5/29/98 : One additional follow-up visit require 30-36 month . ]</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Inclusion Criteria Volunteers must : Normal history physical exam . Negative ELISA Western blot HIV . CD4 count &gt; = 400 cells/mm3 . Normal urine dipstick esterase nitrite . Occupational responsibility preclude compliance . Exclusion Criteria Coexisting Condition : Volunteers follow symptoms condition exclude : Positive hepatitis B surface antigen . Medical psychiatric condition ( recent suicidal ideation present psychosis ) preclude compliance . Active syphilis . NOTE : Subjects serology document false positive due remote ( &gt; 6 month ) treat infection eligible . Active tuberculosis . NOTE : Subjects positive PPD normal chest xray show evidence TB require isoniazid therapy eligible . Allergy egg product neomycin . Volunteers follow prior condition exclude : History immunodeficiency , chronic illness , autoimmune disease use immunosuppressive medication . History anaphylaxis serious adverse reaction vaccine . Prior immunization rabies . History serious allergic reaction substance , require hospitalization emergent medical care ( e.g. , StevensJohnson syndrome , bronchospasm , hypotension ) . Prior psychiatric condition ( history suicide attempt past psychosis ) preclude compliance . History cancer unless surgical excision consider achieved cure . Occupational responsibility preclude compliance . Prior Medication : Excluded : Live attenuate vaccine within 60 day prior study entry . NOTE : Medically indicate kill subunit vaccine ( e.g. , influenza , pneumococcal ) exclude administer least 2 week HIV immunization . Experimental agent within 30 day prior study entry . Prior HIV vaccine . Prior rabies immunization . Prior Treatment : Excluded : Blood product immunoglobulin within 6 month prior study entry . Risk Behavior : Excluded : Identifiable highrisk behavior HIV infection , : injection drug use within past 12 month ; high intermediaterisk sexual behavior . Occupational exposure bird . Low risk sexual behavior .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>HIV Envelope Protein gp120</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Avipoxvirus</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>